Nelson Capital Management’s Novartis NVS Stock Holding History

Nelson Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-614	Closed	-$53K	–	230
2019 Q3	$53K	Buy	614 +300	+96%	+$26.9K	0.01%	146
2019 Q2	$29K	Sell	314 -36	-10%	-$3.05K	0.01%	178
2019 Q1	$30K	Buy	350 +71	+25%	+$5.7K	0.01%	163
2018 Q4	$21K	Sell	279 -56	-17%	-$4.36K	0.01%	190
2018 Q3	$26K	Hold	335	–	–	0.01%	170
2018 Q2	$23K	Hold	335	–	–	0.01%	167
2018 Q1	$24K	Hold	335	–	–	0.01%	178
2017 Q4	$25K	Buy	335 +78	+30%	+$5.88K	0.01%	189
2017 Q3	$20K	Sell	257 -159	-38%	-$12K	0.01%	186
2017 Q2	$31K	Sell	416 -68,586	-99%	-$4.86M	0.01%	153
2017 Q1	$4.59M	Buy	69,002 +831	+1%	+$55.4K	1.54%	37
2016 Q4	$4.45M	Sell	68,171 -5,177	-7%	-$336K	1.55%	35
2016 Q3	$5.19M	Buy	73,348 +1,783	+2%	+$130K	1.84%	28
2016 Q2	$5.29M	Sell	71,565 -134	-0.2%	-$9.26K	1.99%	23
2016 Q1	$4.65M	Sell	71,699 -496	-0.7%	-$33.7K	1.75%	31
2015 Q4	$5.57M	Sell	72,195 -4,247	-6%	-$337K	2.14%	19
2015 Q3	$6.3M	Buy	76,442 +2,604	+4%	+$232K	2.41%	14
2015 Q2	$6.51M	Buy	73,838 +2,439	+3%	+$224K	2.35%	13
2015 Q1	$6.31M	Sell	71,399 -1,557	-2%	-$138K	2.28%	15
2014 Q4	$6.06M	Buy	72,956 +201	+0.3%	+$16.7K	2.24%	15
2014 Q3	$6.14M	Buy	72,755 +2,201	+3%	+$178K	2.32%	16
2014 Q2	$5.72M	Buy	70,554 +4,028	+6%	+$317K	2.29%	18
2014 Q1	$5.07M	Buy	66,526 +1,796	+3%	+$131K	2.23%	17
2013 Q4	$4.66M	Sell	64,730 -1,582	-2%	-$110K	2.07%	18
2013 Q3	$4.56M	Buy	66,312 +988	+2%	+$65.4K	2.17%	21
2013 Q2	$4.14M	Buy	+65,324	New	+$4.25M	2.12%	19

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Nelson Capital Management's NVS Position: Q4 2019 in Review

Nelson Capital Management sold out of Novartis (NVS) in Q4 2019, closing a stake of 614 shares — an estimated $53K sold.

Nelson Capital Management first reported a position in NVS in Q2 2013 and held it in 26 quarters. The position peaked at $6.51M in Q2 2015. 1,173 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

Nelson Capital Management reported no remaining Novartis position as of Q4 2019 after selling out during the quarter.
Nelson Capital Management sold 614 Novartis shares in Q4 2019, an estimated $53K.
Nelson Capital Management first reported a position in Novartis in Q2 2013 and held it in 26 quarters.
Nelson Capital Management's Novartis position peaked at $6.51M in Q2 2015.
1,173 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Nelson Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.